FI59024C - Foerfarande foer framstaellning och rening av en antigen till c-gruppen hoerande meningokockpolysackarid som har hoeg molekylvikt och aer aktiv mot av c-gruppens meningokocker orsakad meningit - Google Patents

Foerfarande foer framstaellning och rening av en antigen till c-gruppen hoerande meningokockpolysackarid som har hoeg molekylvikt och aer aktiv mot av c-gruppens meningokocker orsakad meningit Download PDF

Info

Publication number
FI59024C
FI59024C FI782204A FI782204A FI59024C FI 59024 C FI59024 C FI 59024C FI 782204 A FI782204 A FI 782204A FI 782204 A FI782204 A FI 782204A FI 59024 C FI59024 C FI 59024C
Authority
FI
Finland
Prior art keywords
polysaccharide
och
ethanol
aqueous
solution
Prior art date
Application number
FI782204A
Other languages
English (en)
Finnish (fi)
Other versions
FI782204A (fi
FI59024B (fi
Inventor
Arpi Hagopian
Dennis John Carlo
Thomas Henry Stoudt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI782204A publication Critical patent/FI782204A/fi
Application granted granted Critical
Publication of FI59024B publication Critical patent/FI59024B/fi
Publication of FI59024C publication Critical patent/FI59024C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI782204A 1977-08-01 1978-07-10 Foerfarande foer framstaellning och rening av en antigen till c-gruppen hoerande meningokockpolysackarid som har hoeg molekylvikt och aer aktiv mot av c-gruppens meningokocker orsakad meningit FI59024C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82066577 1977-08-01
US05/820,665 US4123520A (en) 1977-08-01 1977-08-01 Method for preparing high molecular weight meningococcal Group C vaccine

Publications (3)

Publication Number Publication Date
FI782204A FI782204A (fi) 1979-02-02
FI59024B FI59024B (fi) 1981-02-27
FI59024C true FI59024C (fi) 1981-06-10

Family

ID=25231420

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782204A FI59024C (fi) 1977-08-01 1978-07-10 Foerfarande foer framstaellning och rening av en antigen till c-gruppen hoerande meningokockpolysackarid som har hoeg molekylvikt och aer aktiv mot av c-gruppens meningokocker orsakad meningit

Country Status (17)

Country Link
US (1) US4123520A (xx)
JP (1) JPS5446893A (xx)
AR (1) AR222974A1 (xx)
BE (1) BE869406A (xx)
CA (1) CA1112566A (xx)
DE (1) DE2833545A1 (xx)
DK (1) DK308578A (xx)
EG (1) EG13435A (xx)
FI (1) FI59024C (xx)
FR (1) FR2399252A1 (xx)
GB (1) GB2001530B (xx)
IE (1) IE47149B1 (xx)
IT (1) IT1107462B (xx)
LU (1) LU80063A1 (xx)
NL (1) NL7807419A (xx)
ZA (1) ZA784324B (xx)
ZM (1) ZM6778A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460139A1 (fr) * 1979-06-29 1981-01-23 Pasteur Institut Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
EP0109688A3 (en) * 1982-11-23 1986-12-03 The Wellcome Foundation Limited Improved complexes, processes for obtaining them and formulations containing such complexes
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
EP0145359B1 (en) * 1983-11-21 1991-01-16 The Wellcome Foundation Limited Improved complexes, processes for obtaining them and formulations containing such complexes
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
US4877613A (en) * 1987-08-05 1989-10-31 Biotech Connections, Inc. Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli
US5225194A (en) * 1989-11-13 1993-07-06 Ldc Research Corporation Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
US20040213806A1 (en) * 1998-08-28 2004-10-28 Smithkline Beecham Biologicals, S.A. Salmonella typhi vaccine compositions
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
PT2351578T (pt) 2005-06-27 2017-04-07 Glaxosmithkline Biologicals Sa Processo para o fabrico de vacinas
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines

Also Published As

Publication number Publication date
ZM6778A1 (en) 1980-06-20
IE47149B1 (en) 1983-12-28
IT7850445A0 (it) 1978-07-24
FI782204A (fi) 1979-02-02
BE869406A (fr) 1979-01-31
US4123520A (en) 1978-10-31
IT1107462B (it) 1985-11-25
FR2399252A1 (fr) 1979-03-02
JPS5446893A (en) 1979-04-13
NL7807419A (nl) 1979-02-05
CA1112566A (en) 1981-11-17
GB2001530A (en) 1979-02-07
LU80063A1 (fr) 1979-05-15
DE2833545A1 (de) 1979-02-15
GB2001530B (en) 1982-03-03
ZA784324B (en) 1980-03-26
AR222974A1 (es) 1981-07-15
IE781541L (en) 1979-02-01
FI59024B (fi) 1981-02-27
DK308578A (da) 1979-02-02
EG13435A (en) 1981-06-30
FR2399252B1 (xx) 1981-07-31

Similar Documents

Publication Publication Date Title
FI59024C (fi) Foerfarande foer framstaellning och rening av en antigen till c-gruppen hoerande meningokockpolysackarid som har hoeg molekylvikt och aer aktiv mot av c-gruppens meningokocker orsakad meningit
Ribi et al. Endotoxic and antigenic fractions from the cell wall of Salmonella enteritidis. Methods for separation and some biologic activities
US4242501A (en) Purification of pneumococcal capsular polysaccharides
US4271147A (en) Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
US4207414A (en) Polysaccharide antigens
EP0157899A2 (en) Multivalent pneumococcal vaccine and preparation thereof
US4578458A (en) Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa
EP0041897B1 (en) Polysaccharide antigen from streptococcus and vaccines
US4413057A (en) Group B streptococcal capsular polysaccharides
CA1115210A (en) Pneumococcal vaccine
US4349540A (en) Process for preparing vaccines based on antigenic ribosomal fractions
EP0407037A1 (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
US4235994A (en) High molecular weight meningococcal group C vaccine and method for preparation thereof
US4367222A (en) Immune globulin specific to Group B streptococci
US4367223A (en) Vaccine against Group B streptococci
US4356263A (en) Method of making a polysaccharide vaccine
US4367221A (en) Immunization against Group B streptococci
US4386066A (en) Immunogenic complex from N. gonorrhoeae
EP0015846A2 (en) Antigenic sub-cellular cell wall fraction of Bordetella Bronchiseptica, method of obtaining it and composition comprising it
CN110237251B (zh) 一种复合特异性卵黄抗体口腔喷雾剂及其制备方法
DE3781039T2 (de) Vakzine-zusammensetzung zum immunisieren gegen durch e. coli verursachte harnwegeinfektion.
Berman et al. Pilot-scale production of group A and group C meningococcal polysaccharide immunogens
DK141757B (da) Fremgangsmåde til fremstilling af et immunostimulerende glycopeptid fra Corynebacterium parvum.
US4288557A (en) Antigenic complex from N. gonorrhoeae
US4758517A (en) Process for growth of treponema hyodysenteriae

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MERCK & CO INC